placeUnited States
Contact Us

Superior
hernia repair performance 
from many angles.1,†


The ReliaTack™ articulating reloadable fixation device gives you the advantage of better fixation strength.1,†

Read value analysis brief Contact a rep

You want the best for your hernia repair patients—and that means you need fixation solutions you can
depend on.


Surgeons can trust the ReliaTack™ fixation device and its unique, self-tapping design to provide better fixation strength1,† and superior performance at multiple angles.1,†

Delivering standard or deep purchase tacks with a screw-like design, our fixation device provides 65 degrees of articulation for consistent perpendicular tack deployment.2,‡ It’s part of a complete hernia repair portfolio designed to give you stronger fixation.1,3,†,‡

A unique design gives you strength1,† through controlled tack deployment1,2,4,†,§

The unique screw-like tacks of the ReliaTack™ device allow for controlled rotational tack deployment and offer a longer purchase length.1,2,4,†,§ This design provides better fixation strength than nail or prong-style tacks.1,†

Whether the shaft is angled at 30, 45, 65, or 90 degrees, you can depend on consistent tack purchase.2,‡ Based on benchtop testing, the ReliaTack™ device with deep purchase tacks demonstrates superior fixation strength compared to both absorbable and permanent fixation devices at each of these angles.1,†

Watch the ReliaTack™ In-Service

Self-tapping tacks mean
no needle sticks

An unmatched screw-like design allows the ReliaTack™ device’s tacks to self-tap without a piloting needle as they enter tissue. This design allows you to eliminate needle stick hazards while also gaining the advantage of consistent perpendicular tack deployment.2,‡

Different sizes of tacks make the ReliaTack™ fixation device flexible to your OR. Choose between standard or deep purchase tacks to meet your unique patient and procedural needs.

See the articulation in action

Fixation strength1,†
you can rely on

Successful hernia repair depends on successful fixation, and you need a device you can trust to deliver. The deep purchase tacks of the ReliaTack™ device provide more purchase length§ for improved fixation strength.1,†

Based on benchtop testing, the ReliaTack™ device is shown to deliver fixation strength that is 3.3 times stronger than SECURESTRAP™* and 1.7 times stronger than Capsure™*.1,† With performance this reliable,1,† you can trust in successful, strong tack deployment during your procedures.

See the ReliaTack™ difference

Articulation pairs better access3,‡ with better ergonomics4,Ω

With the ReliaTack™ device, you don’t have to compromise between access and surgeon comfort — the two go hand in hand. The articulation of the fixation device improves access3,‡ during laparoscopic ventral hernia repair and also provides a greater level of ergonomic comfort.

Eight out of ten surgeons surveyed said the ReliaTack™ device allowed them to deploy tacks from a more comfortable, ergonomic position.4,Ω 65 degrees of articulation allows you to stand upright while achieving perpendicular tack deployment, fixating the entire mesh from one port, on one side of the patient, and in one comfortable position.2,3,4

Articulation also reduces mesh shift during tacking.3,‡ Compared to nonarticulating devices, the ReliaTack™ device with deep purchase tacks can keep the mesh in a better position during tissue integration.3,‡

Explore the ReliaTack™ product page

Deep purchase tack fixation strength comparison on benchtop testing

ReliaTack™ device deep purchase tack is:

3.9x

Stronger than OptiFix™* absorbable fixation device1,†

3.3x

Stronger than
SECURESTRAP™* 
absorbable fixation device1,†

1.9x

Stronger than SorbaFix™* absorbable fixation device1,†

1.6x

Stronger than ReliaTack™* absorbable fixation device with standard purchase tacks1,†

1.7x

Stronger than CapSure™* permanent fixation device1,†

1.5x

Stronger than ProTack™* permanent fixation device1,†

Additional resources
Hernia repair fixation tack kit product insert
View info east
Parietene™ composite mesh and ReliaTack™ device combo brochure
View brochure east
ReliaTack™ articulating reloadable fixation device optimized VAB
Learn more east
ReliaTack™ device with self-tapping technology
View brochure east

Here to help

Ready to see the difference the ReliaTack™ articulating reloadable fixation device can make in your ventral hernia repair?

Our Medtronic representatives have the knowledge and resources to help you make it part of your hernia repair routine.

Get in touch

†Compared to absorbable and permanent fixation devices commercially available, which include SecureStrap™* device, SorbaFix™* device, OptiFix™* device, Capsure™* device, ProTack™ device and ReliaTack™ device with Standard Purchase Tacks when the shaft is angled at 30°, 45°, 65° and 90°. ReliaTack™ Deep Purchase Tack shear pull test performed in synthetic foam. Results may not correlate to performance in animal or cadaveric tissue, or performance in humans.
‡In comparison to AbsorbaTack™ fixation device.
§Purchase depth is defined as the portion of a tack that is anchored into tissue and which provides resistance to removal. Percentage difference in purchase depth was calculated based on actual tack design length.
ΩIn comparison to nonarticulating fixation devices.

References

1.  Based on internal test report #RE00010135-1, ReliaTack™ Deep Purchase Tack Shear Pull Test performed in synthetic foam. Results may not correlate to performance in animal or cadaveric tissue, or performance in humans. Report p-value = 0.00 October 2015.
2.  Based on internal test report #R2165–050, design verification: Articulation angle engineering. March 2014.
3.  Based on internal test report #R2165-055-1, Mesh Overlap Claims Testing Report. Test performed in a simulated bench model. Results may not correlate to performance in animal or cadaveric tissue, or performance in humans. P-value=0.007 March 2014.
4.  Based on internal test report #R0057955, ReliaTack™ Validation Report: Evaluation in Simulated Use with Surgeons and Nurses. Evaluation involving a total of 21 participants in simulated use conditions. June 2014.